Role of artificial intelligence in the care of patients with non-small cell lung cancer

Publication: European Journal of Clinical Investigation

Rabbani M, Kanevsky J, Kafi K, Chandelier F, Giles FJ

Recent studies support the use of computer‐aided systems and the use of radiomic features to help diagnose lung cancer earlier. Other studies have looked at machine learning (ML) methods that offer prognostic tools to doctors and help them in choosing personalized treatment options for their patients based on molecular, genetics and histological features. Combining artificial intelligence approaches into health care may serve as a beneficial tool for patients with NSCLC, and this review outlines these benefits and current shortcomings throughout the continuum of care